Reporting person on SEC Form 4

Thomas Patrick Kelly

Thomas Patrick Kelly is Chief Financial Officer at Xenon Pharmaceuticals. OQRO lists 1 transaction filed with the SEC under this name, the latest on Oct 1, 2026, each linked to the official Form 4.

Chief Financial Officer

Disclosures on record

1

Companies involved

1

Disclosure history

Xenon PharmaceuticalsXENE
Sep 30, 2026Bought~$560Kdisclosed Oct 1
Details Official record